Posaconazole for chagas disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 2 registered trials.

Why this status

  1. 21 Jun 2011: Trial registered, NCT01377480
  2. 6 Jul 2011: Trial started, NCT01377480

The trials

NCT01162967: Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole

State
Completed
Phase
Phase 2
People
78 taking part
Started
Sep 2010
Primary completion
Dec 2012
Arms
Posaconazole, low dose, Posaconazole, high dose
Results
None posted
  1. 15 Jul 2010: Trial registered

NCT01377480: A Study of the Use of Oral Posaconazole (POS) in the Treatment of Asymptomatic Chronic Chagas Disease (P05267)

State
Completed
Phase
Phase 2
People
120 taking part
Started
6 Jul 2011
Primary completion
22 Jul 2014
Arms
Posaconazole, Posaconazole + Benznidazole
Results
Posted on the registry
  1. 21 Jun 2011: Trial registered
  2. 6 Jul 2011: Trial started
  3. 12 Jan 2015: Trial completed
  4. 10 Aug 2015: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Noxafil.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.